Participation of Prostaglandin E2 in Dopamine D2 Receptor‐Dependent Potentiation of Arachidonic Acid Release
暂无分享,去创建一个
[1] B. Conklin,et al. Hormonal stimulation of adenylyl cyclase through Gi-protein βγ subunits , 1992, Nature.
[2] E. Shohami,et al. Role of the Central Adrenergic System in the Regulation of Prostaglandin Biosynthesis in Rat Brain , 1992, Journal of neurochemistry.
[3] Bruno Giros,et al. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA , 1991, Brain Research.
[4] M. Martres,et al. Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism , 1991, Nature.
[5] J. Axelrod,et al. A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP-mediated arachidonic acid release. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Healy,et al. Characterization of a dopamine receptor (DA2K) in the kidney inner medulla. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[7] D. Sibley,et al. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. , 1991, Molecular pharmacology.
[8] Bruno Giros,et al. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.
[9] P. Greengard,et al. Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling. , 1990, Trends in pharmacological sciences.
[10] S. Ojeda,et al. Epoxygenase products of arachidonic acid are endogenous constituents of the hypothalamus involved in D2 receptor-mediated, dopamine-induced release of somatostatin. , 1990, Endocrinology.
[11] J. Axelrod,et al. Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers , 1988, Trends in Neurosciences.
[12] H. Morris,et al. Platelet activating factor-mediated leukotriene biosynthesis in rat lungs: effect of prostaglandins E1 and F1a , 1987 .
[13] P. Magistretti,et al. Prostaglandins and the synergism between VIP and noradrenaline in the cerebral cortex , 1987, Nature.
[14] O. Hayaishi,et al. Involvement of GTP-regulatory protein in brain prostaglandin E2 receptor and separation of the two components. , 1986, Biochemical and biophysical research communications.
[15] S. Narumiya,et al. Regional Distribution of Prostaglandins D2, E2, and F2α and Related Enzymes in Postmortem Human Brain , 1984, Journal of neurochemistry.
[16] H. Scherrer,et al. Specific binding of [3H]prostaglandin E2 to rat brain membranes and synaptosomes , 1982, Brain Research.
[17] J. Daly,et al. Regulation of cyclic AMP formation in brain tissue by alpha-adrenergic receptors: requisite intermediacy of prostaglandins of the E series. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Morris,et al. Interactions between second messengers: cyclic AMP and phospholipase A2- and phospholipase C-metabolites. , 1991, Life sciences.
[19] N. Mizuno,et al. Specific bindings of prostaglandin D2, E2 and F2 alpha in postmortem human brain. , 1985, Brain research.
[20] R. Stehle. [56] Physical chemistry, stability, and handling of prostaglandins E2, F2α, D2, and I2: A critical summary , 1982 .
[21] F. Coceani,et al. The role of prostaglandins in the central nervous system. , 1979, Annual review of physiology.
[22] M. Muir. Physical Chemistry , 1888, Nature.